Focus on Cranial Dysfunction 

Agenda to come!

Accreditation

This program has been submitted for 7 category 1-A credits from the American Osteopathic Association.

 FOR PURPOSES OF RELICENSURE ONLY, the State Medical Board of Ohio has determined that allopathic physicians may claim AMA PRA Category 1 credit for attending CME programs which are acceptable for AOA Category 1-A credit, as outlined in the American Osteopathic Association (AOA) and the Ohio Osteopathic Association (OOA) CME program.

Learning Objectives

After completing this program, participants should be able to:

• Understand the mechanism of action and the conceptual basis for therapeutic BoNTs in a broad array of clinical conditions
• Review a range of clinical application in which BoNT has been shown to have an effect
• Increase their knowledge of the spectrum of treatments and interventions for these disorders and understand where BoNTs fit into the treatment regimen
• Identify appropriate patients for therapy and determine condition-specific techniques, including injection-site-specific selection and dosing of BoNT
• Understand key considerations involved in establishing treatment plans, including diagnosis and baseline assessment of the patient, recognition of specific symptoms and co-morbidities, and establishment of appropriate expectations for treatment outcomes
• Discuss procedures for administering BoNT therapy
• Recognize the importance of post-injection follow-up and outcomes assessment

****Registration is NOT currently open****

Ohio Neurotoxin Association

5th Annual Educational Conference  (Spring 2012) Registration Form

Name: ____________________________________

Address:___________________________________________________

Phone #: _____________Profession:   DO   MD    DC  RN  Other ________  

Specialty: Neurology  PM&R  Pain Management  Other __________________

AOA/AMA Member #: _______________Email: ______________________

$75  Residents are invited to attend at no charge.

Payment may be made by check or credit card payable to NASH Foundation.